Entyvio
Entyvio
Entyvio (vedolizumab) is used in adults for the treatment of moderate to severe Ulcerative Colitis or Crohn’s Disease.
Entyio works by preventing an excess of white blood cells from entering the GI tract. This helps to control inflammation and symptoms of ulcerative colitis and Crohn’s disease.
Administration Information
Entyvio is administered intravenously over a period of about 30 minutes. An observation time may be required after the infusion.
Entyvio is usually given every 8 weeks. Infusions may be given more frequently at the start of therapy, known as the induction period.
Potential Side Effects
The most common side effects of Entyvio include: common cold, headache, joint pain, nausea, fever, infections of the nose and throat, tiredness, cough, bronchitis, flu, back pain, rash, itching, sinus infection, throat pain, and pain in extremities.
For a full list of potential side effects, please see the Important Safety Information and Medication Guide on the Entyvio website.
Patient Forms
Before you attend your first appointment at Omega Health, please make sure to review the documents below. The Patient Consent Form and HIPAA Privacy Authorization Form need to be filled out and signed ahead of your appointment, whereas the Notice of Privacy Practices and Patient Rights and Responsibilities are for reference only. Please contact us if you have any questions!
Patient Consent Form
Print & Sign
HIPAA Privacy Authorization Form
Print & Sign
Notice of Privacy Practice
Read
Patient Rights and Responsibilities
Read
Appointment Lateness and Cancelation
Read
